Trevi Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$29,065,000 over the previous period. Total operating expenses were $33,923,000.
Profit Margin
| 2017 | 0 | -12.86M | |
|---|---|---|---|
| 2018 | 0 | -20.54M | |
| 2019 | 0 | -26.05M | |
| 2020 | 0 | -32.75M | |
| 2021 | 0 | -33.94M | |
| 2022 | 0 | -29.15M | |
| 2023 | 0 | -29.06M |
TRVI Income Statement (2017 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 123K | 43K | 50K | 47K | 39K | 0 | 0 |
Gross profit | -123K | -43K | -50K | -47K | -39K | 0 | 0 |
Operating exp. | |||||||
Research and development | 23.68M | 19.83M | 22.98M | 22.32M | 19.33M | 14.07M | 6.09M |
Selling and marketing | 287K | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 33.92M | 29.90M | 32.47M | 32.48M | 26.64M | 18.40M | 8.23M |
Operating income | -33.92M | -29.90M | -32.47M | -32.48M | -26.64M | -18.40M | -8.23M |
Other income (expenses), net | 4.82M | 719K | -1.48M | -287K | 577K | -2.24M | -4.64M |
Income before tax | -29.09M | -29.18M | -33.96M | -32.77M | -26.06M | -20.66M | -12.88M |
Income tax expense | -32K | -36K | -21K | -18K | -18K | -124K | -26K |
Net income | -29.06M | -29.15M | -33.94M | -32.75M | -26.05M | -20.54M | -12.86M |
Earnings per share | |||||||
Basic EPS | -0.29 | -0.45 | -1.49 | -1.81 | -2.22 | -2.29 | -1.43 |
Diluted EPS | -0.29 | -0.45 | -1.49 | -1.81 | -2.22 | -2.29 | -1.43 |
| Data source | Data source | Data source | Data source | Data source |